Larvol Delta - Clinical-Trial-to-Evaluate-the-Safety-and-Efficacy-of-IM19-CART-Cells-in-Patients-With-Relapsed-and-Refractory-RR-Bcell-Acute-Lymphoblastic-Leukemia

IM19 CAR-T cells - Immunochina Pharma, Simcere

http://clinicaltrials.gov/ct2/show/NCT05309213

Apr 4, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next